Genome mining of Streptomyces ambofaciens

Area of Science:

• Microbiology
• Genomics
• Natural Product Chemistry

Background:

• Streptomyces species are renowned for producing medically and agriculturally important secondary metabolites.
• The genomic era revealed extensive, previously undiscovered biosynthetic potential within Streptomyces.
• Streptomyces ambofaciens ATCC 23877 was historically known to produce only spiramycin and congocidine.

Purpose of the Study:

• To explore the untapped natural product biosynthetic potential of Streptomyces ambofaciens ATCC 23877.
• To identify novel secondary metabolites through genome mining.
• To compare secondary metabolite gene cluster distribution across related Streptomyces species.

Main Methods:

• Whole-genome sequencing of Streptomyces ambofaciens ATCC 23877.
• Bioinformatic analysis to identify secondary metabolite gene clusters.
• Chemical characterization of compounds derived from identified gene clusters.

Main Results:

• Identification of 23 putative secondary metabolite gene clusters in S. ambofaciens ATCC 23877.
• Characterization of novel compounds and previously undescribed compounds for this species.
• Demonstration that secondary metabolite gene clusters are largely species-specific among closely related Streptomyces.

Conclusions:

• Streptomyces ambofaciens ATCC 23877 possesses a significantly larger secondary metabolome than previously recognized.
• Genome mining is a powerful strategy for discovering novel natural products from microbial sources.
• Understanding species-specific gene clusters aids in targeted natural product discovery and strain improvement.